Kutz Rehabilitation And Nursing | |
704 River Road, Wilmington, Delaware 19809 | |
(302) 764-7000 | |
Name | Kutz Rehabilitation And Nursing |
---|---|
Location | 704 River Road, Wilmington, Delaware |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 90 |
Occupancy Rate | 66.56% |
Medicare ID (CCN) | 085043 |
Legal Business Name | The Milton And Hattie Kutz Home, Inc. |
Ownership Type | Non Profit - Corporation |
NPI Number | 1235135732 |
Organization Name | THE MILTON AND HATTIE KUTZ HOME, INC. |
Address | 704 River Rd, Wilmington, DE 19809 |
Phone Number | 302-764-7000 |
News Archive
Syngenta and Bayer CropScience have entered into a long-term business agreement relating to a key plant biotechnology trait. Under the agreement, Syngenta has granted Bayer CropScience a worldwide, non-exclusive license for use of VIPCOT insect control technology in cotton.
Up to 50% of deaths from cardiovascular disease in Europe could be avoided by implementing population level changes such as taxation and regulation of advertising. Population level prevention will produce greater impacts on CVD than individualised approaches, according to the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) of the European Society of Cardiology (ESC).
Epidermal growth factor receptor (EGFR) is a validated therapeutic target for non-small cell lung cancer. Researchers have now discovered a 93-gene signature that is associated with the presence of EGFR mutations in tumors from lung cancer patients and is a favorable prognostic marker in patients with early stage lung cancer.
STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced CE Mark approval for its nanoFLEX Collamer Single Piece IOL which can be injected through a 2.2 mm incision with the nanoPOINT Injector System.
A study conducted by a team of researchers at the Harvard T.H. Chan School of Public Health has found that for women with an increased concentration of a common type of flame retardant in their urine, there is a decreased possibility of clinical pregnancy as well as live birth when compared to those with a lower concentration.
› Verified 3 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Syngenta and Bayer CropScience have entered into a long-term business agreement relating to a key plant biotechnology trait. Under the agreement, Syngenta has granted Bayer CropScience a worldwide, non-exclusive license for use of VIPCOT insect control technology in cotton.
Up to 50% of deaths from cardiovascular disease in Europe could be avoided by implementing population level changes such as taxation and regulation of advertising. Population level prevention will produce greater impacts on CVD than individualised approaches, according to the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) of the European Society of Cardiology (ESC).
Epidermal growth factor receptor (EGFR) is a validated therapeutic target for non-small cell lung cancer. Researchers have now discovered a 93-gene signature that is associated with the presence of EGFR mutations in tumors from lung cancer patients and is a favorable prognostic marker in patients with early stage lung cancer.
STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced CE Mark approval for its nanoFLEX Collamer Single Piece IOL which can be injected through a 2.2 mm incision with the nanoPOINT Injector System.
A study conducted by a team of researchers at the Harvard T.H. Chan School of Public Health has found that for women with an increased concentration of a common type of flame retardant in their urine, there is a decreased possibility of clinical pregnancy as well as live birth when compared to those with a lower concentration.
› Verified 3 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 1 |
Total Amount of Fines in Dollars | $975 |
Number of Payment Denials | 0 |
Total Number of Penalties | 1 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 16.59 | 14.46 |
Percentage of long-stay residents who lose too much weight | 14.53 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 70.59 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 8.77 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 4.32 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 17.91 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 4.84 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 83.39 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 8.33 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 53.4 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 28.97 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 19.59 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 7.54 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.34 | 95.98 |
Percentage of short-stay residents who made improvements in function | 73.39 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 72.22 | 82.93 |
News Archive
Syngenta and Bayer CropScience have entered into a long-term business agreement relating to a key plant biotechnology trait. Under the agreement, Syngenta has granted Bayer CropScience a worldwide, non-exclusive license for use of VIPCOT insect control technology in cotton.
Up to 50% of deaths from cardiovascular disease in Europe could be avoided by implementing population level changes such as taxation and regulation of advertising. Population level prevention will produce greater impacts on CVD than individualised approaches, according to the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) of the European Society of Cardiology (ESC).
Epidermal growth factor receptor (EGFR) is a validated therapeutic target for non-small cell lung cancer. Researchers have now discovered a 93-gene signature that is associated with the presence of EGFR mutations in tumors from lung cancer patients and is a favorable prognostic marker in patients with early stage lung cancer.
STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced CE Mark approval for its nanoFLEX Collamer Single Piece IOL which can be injected through a 2.2 mm incision with the nanoPOINT Injector System.
A study conducted by a team of researchers at the Harvard T.H. Chan School of Public Health has found that for women with an increased concentration of a common type of flame retardant in their urine, there is a decreased possibility of clinical pregnancy as well as live birth when compared to those with a lower concentration.
› Verified 3 days ago
Kentmere Rehabilitation And Healthcare Center Location: 1900 Lovering Avenue, Wilmington, Delaware 19806 Phone: (302) 652-3311 | |
Willowbrooke Court At Country House Location: 4830 Kennett Pike, Wilmington, Delaware 19807 Phone: (302) 654-5101 | |
Springs Rehabilitation At Brandywine Location: 505 Greenbank Road, Wilmington, Delaware 19808 Phone: (302) 998-0101 | |
Regency Healthcare & Rehab Center Location: 801 N. Broom Street, Wilmington, Delaware 19806 Phone: (302) 654-8400 | |
Complete Care At Hillside Llc Location: 810 South Broom Street, Wilmington, Delaware 19805 Phone: (302) 652-1181 |